País: Israel
Idioma: inglés
Fuente: Ministry of Health
AXITINIB
TEVA ISRAEL LTD
L01XE17
FILM COATED TABLETS
AXITINIB 5 MG
PER OS
Required
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
AXITINIB
For the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy
2020-02-23